Molecular Epidemiology of Adenovirus Type 21 Respiratory Strains Isolated From US Military Trainees (1996-2014)

Journal of Infectious Diseases

Volumn 212, Issue 6, 2015, Pages 871-880

  Kajon, Adriana E ^a   Hang, Jun ^b   Hawksworth, Anthony ^c   Metzgar, David ^c,f   Hage, Elias ^d   Hansen, Christian J ^c   Kuschner, Robert A ^b   Blair, Patrick ^c,g   Russell, Kevin L ^e   Jarman, Richard G ^b  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e Armed Forces Health Surveillance Center (AFHSC)   (United States)

^f ABBOTT LABORATORIES   (United States)

^g US Naval Medical Research Unit No 3 Egypt   (Egypt)

Author keywords

adenovirus evolution; DNA; military; molecular epidemiology

Indexed keywords

ADENOVIRIDAE; ADENOVIRUS INFECTION; ADULT; ASIA; CHILD; CLUSTER ANALYSIS; CONFERENCE PAPER; DISEASE SURVEILLANCE; EUROPE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN ADENOVIRUS TYPE 21; HUMAN ADENOVIRUS TYPE 21 INFECTION; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RESTRICTION MAPPING; SAUDI ARABIA; SOLDIER; UNITED STATES; VIRAL RESPIRATORY TRACT INFECTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS STRAIN; ADENOVIRIDAE INFECTIONS; CLASSIFICATION; EPIDEMIC; GENETICS; HEALTH SURVEY; HUMAN ADENOVIRUS C; ISOLATION AND PURIFICATION; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; TIME; VIROLOGY;

VIRUS DNA;

ADENOVIRIDAE INFECTIONS; ADENOVIRUSES, HUMAN; DISEASE OUTBREAKS; DNA, VIRAL; GENETIC VARIATION; HUMANS; MILITARY PERSONNEL; MOLECULAR EPIDEMIOLOGY; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; TIME FACTORS; UNITED STATES;

EID: 84940729766     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv141     Document Type: Conference Paper

References (49)

1. Wold WSM, Ison MG. Adenovirus. In: Knipe DM, Howley PM, eds. Fields virology. 6th ed. Philadelphia: Lippincott, Williams & Wilkins, 2013:1732-67.
2. Hilleman MR, Werner JH. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med 1954; 85:183-8.
3. Barraza EM, Ludwig SL, Gaydos JC, Brundage JF. Reemergence of adenovirus type 4 acute respiratory disease in military trainees: report of an outbreak during a lapse in vaccination. J Infect Dis 1999; 179:1531-3.
4. Gray GC, Goswami PR, Malasig MD, et al; for the Adenovirus Surveillance Group. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. Clin Infect Dis 2000; 31:663-70.
5. Rose HM, Lamson TH, Buescher EL. Adenoviral infection in military recruits. Arch Environ Health 1970; 21:356-61.
6. Sanchez JL, Binn LN, Innis BL, et al. Epidemic of adenovirus-induced respiratory illness among US military recruits: epidemiologic and immunologic risk factors in healthy, young adults. J Med Virol 2001; 65:710-8.
7. Dudding BA, Top FH Jr, Winter PE, Buescher EL, Lamson TH, Leibovitz A. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. Am J Epidemiol 1973; 97:187-98.
8. Kolavic S, Binn LN, Sanchez JL, et al. Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical and laboratory studies. Clin Infect Dis 2002; 35:808-18.
9. Russell KL, Hawksworth AW, Ryan MA, et al. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine 2006; 24:2835-42.
10. Sanford JP. Acute respiratory disease in the United States Army in the Republic of Vietnam, 1965-1970. Yale J Biol Med 1975; 48:179-84.
11. Top FH Jr, Dudding BA, Russell PK, Buescher EL. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol 1971; 94:142-6.
12. Top FH Jr, Grossman RA, Bartelloni PJ, et al. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis 1971; 124:148-54.
13. Hoke CH Jr, Hawksworth A, Snyder CE Jr. Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012. MSMR 2012; 19:2-4.
14. Radin JM, Hawksworth AW, Blair PJ, et al. Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines. Clin Infect Dis 2014; 59:962-8.
15. Bell SD Jr, McComb DE, Murray ES, Chang RS, Snyder JC. Adenoviruses isolated from Saudi Arabia. I. Epidemiologic features. Am J Trop Med Hyg 1959; 8:492-500.
16. van der Veen J, Dijkman JH. Association of type 21 adenovirus with acute respiratory illness in military recruits. Am J Hyg 1962; 76:149-59.
17. Blasiole DA, Metzgar D, Daum LT, et al. Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults. J Clin Microbiol 2004; 42:1686-93.
18. Dudding BA, Bartelloni PJ, Scott RM, Top FH Jr, Russell PK, Buescher EL. Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers. Infect Immun 1972; 5:295-99.
19. Scott RM, Dudding BA, Romano SV, Russell PK. Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization. Infect Immun 1972; 5:300-4.
20. Takafuji ET, Gaydos JC, Allen RG, Top FH Jr. Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity. J Infect Dis 1979; 140:48-53.
21. van der Veen J, Oei KG, Abarbanel MF. Patterns of infections with adenovirus types 4, 7 and 21 in military recruits during a 9-year survey. J Hyg (Lond) 1969; 67:255-68.
22. Pereira MS. Occurrence of adenovirus type 21 in Great Britain. BMJ 1963; 1:728-9.
23. Higgins PG. Virus isolations from patients in general practice, 1961-71. J Hyg (Lond) 1974; 72:255-64.
24. van der Avoort HG, Adrian T, Wigand R, Wermenbol AG, Zomerdijk TP, de Jong JC. Molecular epidemiology of adenovirus type 21 in the Netherlands and the Federal Republic of Germany from 1960 to 1985. J Clin Microbiol 1986; 24:1084-8.
25. Lang WR, Howden CW, Laws J, Burton JF. Bronchopneumonia with serious sequelae in children with evidence of adenovirus type 21 infection. BMJ 1969; 1:73-9.
26. Henson D, Mufson MA. Myocarditis and pneumonitis with type 21 adenovirus infection. Association with fatal myocarditis and pneumonitis. Am J Dis Child 1971; 121:334-6.
27. Becroft DM. Bronchiolitis obliterans, bronchiectasis, and other sequelae of adenovirus type 21 infection in young children. J Clin Pathol 1971; 24:72-82.
28. James AG, Lang WR, Liang AY, et al. Adenovirus type 21 bronchopneumonia in infants and young children. J Pediatr 1979; 95:530-3.
29. Wright J, Couchonnal G, Hodges GR. Adenovirus type 21 infection. Occurrence with pneumonia, rhabdomyolysis, and myoglobinuria in an adult. JAMA 1979; 241:2420-1.
30. Pearson RD, Hall WJ, Menegus MA, Douglas RG Jr. Diffuse pneumonitis due to adenovirus type 21 in a civilian. Chest 1980; 78:107-9.
31. Hierholzer JC, Torrence AE, Wright PF. Generalized viral illness caused by an intermediate strain of adenovirus (21/H21+35). J Infect Dis 1980; 141:281-8.
32. Ooi MH, Wong SC, Clear D, et al. Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia. Clin Infect Dis 2003; 36:550-9.
33. Hage E, Huzly D, Ganzenmüller T, Beck R, Schulz TF, Heim A. A human adenovirus species B subtype 21a associated with severe pneumonia. J Infect 2014; 69:490-9.
34. Adrian T, Wigand R, Hierholzer JC. Immunological and biochemical characterization of human adenoviruses from subgenus B. II. DNA restriction analysis. Arch Virol 1985; 84:79-89.
35. Malasig MD, Goswami PR, Crawford-Miksza LK, Schnurr DP, Gray GC. Simplified microneutralization test for serotyping adenovirus isolates. J Clin Microbiol 2001; 39:2984-6.
36. Metzgar D, Osuna M, Yingst S, et al. PCR analysis of Egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections. J Clin Microbiol 2005; 43:5743-52.
37. Shinagawa M, Matsuda A, Ishiyama T, Goto H, Sato G. A rapid and simple method for preparation of adenovirus DNA from infected cells. Microbiol Immunol 1983; 27:817-22.
38. Kajon AE, Erdman DD. Assessment of genetic variability among subspecies B1 human adenoviruses for molecular epidemiology studies. Methods Mol Med 2007; 131:335-55.
39. Li QG, Wadell G. Analysis of 15 different genome types of adenovirus type 7 isolated on five continents. J Virol 1986; 60:331-5.
40. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular Evolutionary Genetics Analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28:2731-39.
41. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucl Acids Res 2004; 32:1792-7.
42. Crawford-Miksza L, Schnurr DP. Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. J Virol 1996; 70:1836-44.
43. Crawford-Miksza LK, Schnurr DP. Adenovirus serotype evolution is driven by illegitimate recombination in the hypervariable regions of the hexon protein. Virology 1996; 224:357-67.
44. Shult PA, Polyak F, Dick EC, Warshauer DM, King LA, Mandel AD. Adenovirus 21 infection in an isolated Antarctic station: transmission of the virus and susceptibility of the population. Am J Epidemiol 1991; 133:599-607.
45. Couch RB, Knight V, Douglas RG Jr, Black SH, Hamory BH. The minimal infectious dose of adenovirus type 4; the case for natural transmission by viral aerosol. Trans Am Clin Climatol Assoc 1969; 80: 205-11.
46. Uemura T, Kawashitam T, Ostuka Y, Tanaka Y, Kusubae R, Yoshinaga M. A recent outbreak of adenovirus type 7 infection in a chronic inpatient facility for the severely handicapped. Infect Control Hosp Epidemiol 2000; 21:559-60.
47. Gerber SI, Erdman DD, Pur SL, et al. Outbreak of adenovirus genome type 7d2 infection in a pediatric chronic-care facility and tertiary-care hospital. Clin Infect Dis 2001; 32:694-700.
48. Russell KL, Broderick MP, Franklin SE, et al. Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting. J Infect Dis 2006; 194:877-85.
49. Tate JE, Bunning ML, Lott L, et al. Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US Air Force training facility in 2007. J Infect Dis 2009; 199:1419-26.